chr14-69209598-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001193360.2(EXD2):c.128C>T(p.Pro43Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000935 in 1,550,406 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001193360.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EXD2 | NM_001193360.2 | c.128C>T | p.Pro43Leu | missense_variant | 3/10 | ENST00000685843.1 | NP_001180289.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EXD2 | ENST00000685843.1 | c.128C>T | p.Pro43Leu | missense_variant | 3/10 | NM_001193360.2 | ENSP00000510642.1 |
Frequencies
GnomAD3 genomes AF: 0.0000658 AC: 10AN: 152086Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000423 AC: 64AN: 151138Hom.: 1 AF XY: 0.000332 AC XY: 27AN XY: 81210
GnomAD4 exome AF: 0.0000965 AC: 135AN: 1398320Hom.: 2 Cov.: 31 AF XY: 0.0000971 AC XY: 67AN XY: 689682
GnomAD4 genome AF: 0.0000658 AC: 10AN: 152086Hom.: 0 Cov.: 31 AF XY: 0.0000404 AC XY: 3AN XY: 74276
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 09, 2021 | The c.128C>T (p.P43L) alteration is located in exon 3 (coding exon 1) of the EXD2 gene. This alteration results from a C to T substitution at nucleotide position 128, causing the proline (P) at amino acid position 43 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at